Cargando…

Alemtuzumab in Covid era

BACKGROUND: The SARS-CoV-2 pandemic impact on people with Multiple Sclerosis (pwMS) continues to worry. The disease modifying therapies in pwMS can add a more severe risk of infection when compared to the general population. Alemtuzumab is an anti-CD52 monoclonal antibody and it is one of the most i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Iovino, Aniello, Olivieri, Nunzio, Aruta, Francesco, Giaquinto, Emanuele, Ruggiero, Lucia, Spina, Emanuele, Tozza, Stefano, Manganelli, Fiore, Iodice, Rosa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier B.V. 2021
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7969858/ https://www.ncbi.nlm.nih.gov/pubmed/33812222 http://dx.doi.org/10.1016/j.msard.2021.102908

Ejemplares similares

Primary Progressive Multiple Sclerosis Under Anti-TNFα Treatment: A Case Report
por: Iovino, Aniello, et al.
Publicado: (2020)

The neuropathy in hereditary transthyretin amyloidosis: A narrative review
por: Tozza, Stefano, et al.
Publicado: (2021)

Value of Antibody Determinations in Chronic Dysimmune Neuropathies
por: Tozza, Stefano, et al.
Publicado: (2022)

The impact of symptoms on daily life as perceived by patients with Charcot-Marie-Tooth type 1A disease
por: Tozza, Stefano, et al.
Publicado: (2021)

A case of severe increase of liver enzymes in a ATTRv patient after one year of inotersen treatment
por: Severi, Daniele, et al.
Publicado: (2022)

A compound score to screen patients with hereditary transthyretin amyloidosis
por: Tozza, Stefano, et al.
Publicado: (2022)

How to manage with telemedicine people with neuromuscular diseases?
por: Spina, Emanuele, et al.
Publicado: (2021)

Bedside Head Impulse Test: A Useful Tool for Patients With Sensory Ataxia
por: Tozza, Stefano, et al.
Publicado: (2020)

Facioscapulohumeral muscular dystrophy (FSHD) and multiple sclerosis: a case report
por: Iodice, Rosa, et al.
Publicado: (2020)

Telemedicine application to headache: a critical review
por: Spina, Emanuele, et al.
Publicado: (2022)

Multimodal evaluation of an Italian family with a hereditary spastic paraplegia and POLR3A mutations
por: Ruggiero, Lucia, et al.
Publicado: (2020)

One-year follow up of three Italian patients with Duchenne muscular dystrophy treated with ataluren: is earlier better?
por: Ruggiero, Lucia, et al.
Publicado: (2018)

Quantitative Sensory Testing in Late-Onset ATTRv Presymptomatic Subjects: A Single Center Experience
por: Tozza, Stefano, et al.
Publicado: (2022)

In vivo evidence of cortical amyloid deposition in the adult form of Niemann Pick type C
por: Esposito, Marcello, et al.
Publicado: (2019)

COVID-19 and multiple sclerosis: A description of two cases on alemtuzumab
por: Fernández-Díaz, Eva, et al.
Publicado: (2020)

COVID-19 in a multiple sclerosis (MS) patient treated with alemtuzumab: Insight to the immune response after COVID
por: Fiorella, Celsi, et al.
Publicado: (2020)

Mild COVID-19 infection in a patient with multiple sclerosis and severe depletion of T-lymphocyte subsets due to alemtuzumab
por: Guevara, Carlos, et al.
Publicado: (2020)

Brainstem involvement and respiratory failure in COVID-19
por: Manganelli, Fiore, et al.
Publicado: (2020)

Multiple cranial neuropathy due to varicella zoster virus reactivation without vesicular rash: a challenging diagnosis
por: Stornaiuolo, Antonio, et al.
Publicado: (2023)

Hidradenitis suppurativa and adalimumab in the COVID-19 era
por: Marzano, Angelo Valerio, et al.
Publicado: (2021)

Alemtuzumab
por: Tridente, Giuseppe
Publicado: (2013)

Brain Plasticity in Charcot-Marie-Tooth Type 1A Patients? A Combined Structural and Diffusion MRI Study
por: Pontillo, Giuseppe, et al.
Publicado: (2020)

25-Hydroxy-Vitamin D and Risk of Recurrent Stroke: A Dose Response Meta-Analysis
por: Vergatti, Anita, et al.
Publicado: (2023)

Balneotherapy and human immune function in the era of COVID-19
por: Masiero, Stefano, et al.
Publicado: (2020)

Clinical features of Pompe disease
por: MANGANELLI, FIORE, et al.
Publicado: (2013)

Health resort therapy interventions in the COVID-19 pandemic era: what next?
por: Masiero, Stefano, et al.
Publicado: (2021)

An andrologist in the front line Covid-19 team
por: Baldassarre, Emanuele
Publicado: (2020)

Strongyloidiasis in the COVID era: a warning for an implementation of the screening protocol
por: Vellere, Iacopo, et al.
Publicado: (2021)

Rheumatic disease management in the Campania region of Italy during the COVID-19 pandemic
por: Masini, Francesco, et al.
Publicado: (2020)

Intestinal ischemia in the COVID-19 era
por: Norsa, Lorenzo, et al.
Publicado: (2020)

Reply to Oppersma et al.
por: Marrazzo, Francesco, et al.
Publicado: (2022)

Alemtuzumab for Multiple Sclerosis
por: Willis, Mark D., et al.
Publicado: (2016)

Tackling the pillars of ageing to fight COVID-19
por: Prattichizzo, Francesco, et al.
Publicado: (2021)

Alemtuzumab: COVID-19 infection: case report
Publicado: (2020)

Surgical Training in the Era of COVID-19: Reply
por: Fuller, Stephanie
Publicado: (2021)

Unmasking Facial Tinea in the COVID-19 Era
por: Abraham, Anil, et al.
Publicado: (2021)

Acute Encephalitis Beyond the Usual in the COVID Era
por: Pal, Priyankar, et al.
Publicado: (2021)

The COVID-19 era: Ethics in times of crisis()
por: Gamboa-Antiñolo, F.-M.
Publicado: (2021)

Balneotherapy in the era of COVID-19: should it be recommended or not?
por: Guvener, Orhan
Publicado: (2020)

The unmet need for COVID-19 treatment in immunocompromised patients
por: Alessandra, D’Abramo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_r7opornrunh16t1s0tev79slvo